IL-12
7 drugs Immunology
4
approved indications
7
Approved Drugs
7
Companies
6
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (7 companies)
✓ All 7 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (6 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
ALVOTECH USA INC 1 drug
Amgen 1 drug
Johnson & Johnson 1 drug
By Therapeutic Area
Immunology 7 drugs
By Therapeutic Area
Immunology 7 drugs
SELARSDI, WEZLANA, STELARA, OTULFI +3 more
Indications Treated
Plaque PsoriasisPsoriatic ArthritisCrohn’s DiseaseUlcerative ColitisCrohn's DiseaseCrohn Disease
All Drugs Targeting IL-12
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| SELARSDI | ALVOTECH USA INC | 2024 | 4 | Immunology |
| WEZLANA | Amgen | 2023 | 4 | Immunology |
| STELARA | Johnson & Johnson | 2009 | 4 | Immunology |
| OTULFI | Fresenius Kabi | 2024 | 4 | Immunology |
| STARJEMZA | BIO-THERA SOLUTIONS LTD | 2025 | 4 | Immunology |
| IMULDOSA | ACCORD BIOPHARMA INC. | 2024 | 4 | Immunology |
| YESINTEK | BIOCON BIOLOGICS INC | 2024 | 4 | Immunology |